MEDIFAST Return On Assets vs Non Current Liabilities Total Analysis
MED Stock | USD 35.23 1.52 4.51% |
MEDIFAST INC financial indicator trend analysis is infinitely more than just investigating MEDIFAST INC recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether MEDIFAST INC is a good investment. Please check the relationship between MEDIFAST INC Return On Assets and its Non Current Liabilities Total accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in MEDIFAST INC. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income. For information on how to trade MEDIFAST Stock refer to our How to Trade MEDIFAST Stock guide.
Return On Assets vs Non Current Liabilities Total
Return On Assets vs Non Current Liabilities Total Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of MEDIFAST INC Return On Assets account and Non Current Liabilities Total. At this time, the significance of the direction appears to have strong relationship.
The correlation between MEDIFAST INC's Return On Assets and Non Current Liabilities Total is 0.61. Overlapping area represents the amount of variation of Return On Assets that can explain the historical movement of Non Current Liabilities Total in the same time period over historical financial statements of MEDIFAST INC, assuming nothing else is changed. The correlation between historical values of MEDIFAST INC's Return On Assets and Non Current Liabilities Total is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Return On Assets of MEDIFAST INC are associated (or correlated) with its Non Current Liabilities Total. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Non Current Liabilities Total has no effect on the direction of Return On Assets i.e., MEDIFAST INC's Return On Assets and Non Current Liabilities Total go up and down completely randomly.
Correlation Coefficient | 0.61 |
Relationship Direction | Positive |
Relationship Strength | Significant |
Return On Assets
A profitability ratio that indicates the percentage of profit a company earns in relation to its overall resources. It is calculated by dividing net income by total assets.Non Current Liabilities Total
Most indicators from MEDIFAST INC's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into MEDIFAST INC current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in MEDIFAST INC. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income. For information on how to trade MEDIFAST Stock refer to our How to Trade MEDIFAST Stock guide.At present, MEDIFAST INC's Discontinued Operations is projected to increase significantly based on the last few years of reporting. The current year's Enterprise Value is expected to grow to about 417.1 M, whereas Sales General And Administrative To Revenue is forecasted to decline to 0.48.
2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 1.1B | 1.1B | 775.9M | 814.6M | Total Revenue | 1.5B | 1.6B | 1.1B | 1.1B |
MEDIFAST INC fundamental ratios Correlations
Click cells to compare fundamentals
MEDIFAST INC Account Relationship Matchups
High Positive Relationship
High Negative Relationship
MEDIFAST INC fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 194.7M | 276.1M | 398.3M | 316.2M | 309.9M | 325.4M | |
Other Current Liab | 49.3M | 64.3M | 84.4M | 69.1M | 46.6M | 49.0M | |
Total Current Liabilities | 79.4M | 111.4M | 169.8M | 140.9M | 92.3M | 96.9M | |
Total Stockholder Equity | 104.8M | 157.2M | 202.5M | 155.0M | 201.5M | 211.6M | |
Property Plant And Equipment Net | 38.8M | 38.1M | 80.6M | 75.6M | 67.1M | 70.5M | |
Net Debt | (63.4M) | (152.6M) | (71.6M) | (61.6M) | (72.4M) | (68.8M) | |
Retained Earnings | 168.8M | 154.4M | 190.3M | 139.9M | 174.6M | 183.4M | |
Cash | 77.0M | 163.7M | 104.2M | 87.7M | 94.4M | 99.2M | |
Non Current Assets Total | 40.5M | 41.8M | 91.5M | 93.4M | 85.9M | 90.2M | |
Non Currrent Assets Other | 353K | 2.9M | 6.5M | 12.5M | 14.7M | 15.4M | |
Cash And Short Term Investments | 92.7M | 174.5M | 109.5M | 87.7M | 150.0M | 157.5M | |
Net Receivables | 1.0M | 1.4M | 584K | 1.0 | 8.7M | 9.2M | |
Common Stock Shares Outstanding | 12.1M | 11.9M | 11.8M | 11.3M | 10.9M | 12.2M | |
Liabilities And Stockholders Equity | 194.7M | 276.1M | 398.3M | 316.2M | 309.9M | 325.4M | |
Non Current Liabilities Total | 10.4M | 7.5M | 26.0M | 20.3M | 16.1M | 16.9M | |
Inventory | 48.8M | 53.4M | 180.0M | 118.9M | 54.6M | 27.8M | |
Other Current Assets | 11.3M | 5.9M | 17.3M | 16.2M | 10.7M | 5.5M | |
Other Stockholder Equity | (64.0M) | 2.8M | 12.0M | 15.2M | 26.6M | 27.9M | |
Total Liab | 89.8M | 118.8M | 195.9M | 161.2M | 108.4M | 113.8M | |
Property Plant And Equipment Gross | 38.8M | 38.1M | 113.3M | 115.6M | 114.4M | 120.1M | |
Total Current Assets | 154.2M | 234.3M | 306.9M | 222.8M | 224.0M | 235.2M | |
Short Term Debt | 3.2M | 3.7M | 6.5M | 5.8M | 5.9M | 6.2M | |
Accounts Payable | 22.6M | 35.8M | 70.9M | 58.7M | 39.2M | 21.4M | |
Accumulated Other Comprehensive Income | 25K | 41K | 111K | 24K | 248K | 260.4K | |
Other Assets | 1.7M | 14.1M | 10.9M | 17.8M | 20.5M | 21.5M | |
Short Term Investments | 15.7M | 10.8M | 5.4M | (23K) | 55.6M | 58.4M | |
Property Plant Equipment | 26.0M | 27.6M | 56.1M | 57.2M | 65.8M | 69.1M | |
Net Tangible Assets | 104.8M | 157.2M | 202.5M | 155.0M | 178.3M | 125.0M | |
Retained Earnings Total Equity | 168.8M | 154.4M | 190.3M | 139.9M | 160.8M | 126.9M | |
Capital Surpluse | 0.0 | 7.8M | 12.0M | 21.6M | 19.4M | 10.8M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in MEDIFAST INC. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income. For information on how to trade MEDIFAST Stock refer to our How to Trade MEDIFAST Stock guide.Note that the MEDIFAST INC information on this page should be used as a complementary analysis to other MEDIFAST INC's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Complementary Tools for MEDIFAST Stock analysis
When running MEDIFAST INC's price analysis, check to measure MEDIFAST INC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MEDIFAST INC is operating at the current time. Most of MEDIFAST INC's value examination focuses on studying past and present price action to predict the probability of MEDIFAST INC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MEDIFAST INC's price. Additionally, you may evaluate how the addition of MEDIFAST INC to your portfolios can decrease your overall portfolio volatility.
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |
Is MEDIFAST INC's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of MEDIFAST INC. If investors know MEDIFAST will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about MEDIFAST INC listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.77) | Dividend Share 4.95 | Earnings Share 9.1 | Revenue Per Share 98.498 | Quarterly Revenue Growth (0.43) |
The market value of MEDIFAST INC is measured differently than its book value, which is the value of MEDIFAST that is recorded on the company's balance sheet. Investors also form their own opinion of MEDIFAST INC's value that differs from its market value or its book value, called intrinsic value, which is MEDIFAST INC's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because MEDIFAST INC's market value can be influenced by many factors that don't directly affect MEDIFAST INC's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between MEDIFAST INC's value and its price as these two are different measures arrived at by different means. Investors typically determine if MEDIFAST INC is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, MEDIFAST INC's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.